Merck Tbk PT MERK.JK · IDR

Health Care · IDX · 🇮🇩 Indonesia

Compare

3,450

-1.15%

Close of 9 Nov 2026, in IDR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in IDR, from our data supplier.

FY2025

Revenue

IDR 1.20trn

FY2016FY2025

Net income

IDR 243.90bn

FY2016FY2025

Free cash flow

IDR 360.90bn

FY2016FY2025

Shareholders' equity

IDR 975.71bn

FY2016FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	IDR 1.20trn	IDR 1.04trn	IDR 961.43bn	IDR 1.12trn	IDR 1.06trn	IDR 655.85bn	IDR 744.63bn	IDR 611.96bn	IDR 1.16trn	IDR 1.03trn
Gross profit	IDR 562.44bn	IDR 402.67bn	IDR 400.47bn	IDR 427.59bn	IDR 398.68bn	IDR 294.21bn	IDR 323.31bn	IDR 211.69bn	IDR 587.99bn	IDR 542.19bn
Research and development	—	IDR 347.6m	IDR 541.8m	IDR 288.2m	IDR 166.7m	IDR 188.8m	IDR 113.5m	IDR 1.13bn	IDR 3.90bn	IDR 1.80bn
Operating income	IDR 320.43bn	IDR 192.96bn	IDR 199.73bn	IDR 239.07bn	IDR 191.53bn	IDR 108.53bn	IDR 125.59bn	IDR 47.13bn	IDR 208.49bn	IDR 213.30bn
Net income	IDR 243.90bn	IDR 153.46bn	IDR 178.24bn	IDR 179.84bn	IDR 131.66bn	IDR 71.90bn	IDR 78.26bn	IDR 1.16trn	IDR 144.68bn	IDR 153.84bn
Diluted earnings per share	544.41	342.55	397.86	401.42	293.89	160.50	174.68	2,596.71	322.94	343.40

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Total assets	IDR 1.27trn	IDR 956.94bn	IDR 957.81bn	IDR 1.04trn	IDR 1.03trn	IDR 929.90bn	IDR 901.06bn	IDR 1.26trn	IDR 847.01bn	IDR 743.93bn
Cash and short-term investments	IDR 442.46bn	IDR 87.68bn	IDR 201.44bn	IDR 170.43bn	IDR 196.34bn	IDR 134.73bn	IDR 161.47bn	IDR 403.19bn	IDR 59.47bn	IDR 114.44bn
Total liabilities	IDR 296.49bn	IDR 149.66bn	IDR 161.94bn	IDR 280.41bn	IDR 342.22bn	IDR 317.22bn	IDR 307.05bn	IDR 744.83bn	IDR 231.57bn	IDR 161.26bn
Debt	IDR 14.23bn	IDR 20.21bn	IDR 18.13bn	IDR 16.18bn	IDR 20.28bn	IDR 22.02bn	IDR 1.24bn	IDR 2.87bn	IDR 3.28bn	—
Shareholders' equity	IDR 975.71bn	IDR 807.27bn	IDR 795.88bn	IDR 757.24bn	IDR 684.04bn	IDR 612.68bn	IDR 594.01bn	IDR 518.28bn	IDR 615.44bn	IDR 582.67bn
Shares outstanding	448m	448m	448m	448m	448m	448m	448m	448m	448m	448m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash from operations	IDR 376.52bn	IDR 55.71bn	IDR 203.87bn	IDR 110.32bn	IDR 169.81bn	IDR 71.98bn	−IDR 210.84bn	IDR 168.96bn	IDR 129.92bn	IDR 43.80bn
Capital spending	−IDR 15.62bn	−IDR 16.83bn	−IDR 19.90bn	−IDR 20.18bn	−IDR 43.09bn	−IDR 31.42bn	−IDR 29.90bn	−IDR 23.86bn	−IDR 65.54bn	−IDR 25.49bn
Free cash flow	IDR 360.90bn	IDR 38.88bn	IDR 183.97bn	IDR 90.14bn	IDR 126.72bn	IDR 40.56bn	−IDR 240.74bn	IDR 145.10bn	IDR 64.38bn	IDR 18.31bn
Dividends paid	−IDR 76.16bn	−IDR 142.91bn	−IDR 143.89bn	−IDR 107.27bn	−IDR 55.25bn	−IDR 57.64bn	−IDR 1.02bn	−IDR 1.26trn	−IDR 122.49bn	−IDR 44.71bn

Latest quarters

By quarter end

	Jun 2026	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024
Revenue	IDR 347.13bn	IDR 283.11bn	IDR 386.56bn	IDR 333.95bn	IDR 265.00bn	IDR 215.16bn	IDR 283.01bn	IDR 282.53bn
Gross profit	IDR 114.39bn	IDR 111.68bn	IDR 290.98bn	IDR 152.21bn	IDR 63.56bn	IDR 63.10bn	IDR 161.66bn	IDR 88.80bn
Operating income	IDR 56.37bn	IDR 68.03bn	IDR 214.09bn	IDR 98.97bn	IDR 13.86bn	IDR 16.45bn	IDR 95.83bn	IDR 39.34bn
Net income	IDR 46.60bn	IDR 65.18bn	IDR 141.80bn	IDR 79.59bn	IDR 9.32bn	IDR 13.19bn	IDR 76.41bn	IDR 29.21bn
Diluted earnings per share	104.01	145.49	316.51	177.65	20.80	29.45	170.55	65.21
Cash from operations	IDR 8.48bn	IDR 86.54bn	IDR 198.47bn	IDR 17.55bn	IDR 137.63bn	IDR 22.86bn	IDR 28.90bn	−IDR 164.0m
Capital spending	−IDR 4.55bn	−IDR 5.36bn	−IDR 3.90bn	−IDR 6.16bn	−IDR 4.35bn	−IDR 1.21bn	−IDR 12.27bn	−IDR 3.37bn
Free cash flow	IDR 3.93bn	IDR 81.19bn	IDR 194.57bn	IDR 11.39bn	IDR 133.28bn	IDR 21.65bn	IDR 16.63bn	−IDR 3.53bn
Total assets	IDR 1.23trn	IDR 1.32trn	IDR 1.27trn	IDR 987.93bn	IDR 1.01trn	IDR 982.69bn	IDR 956.94bn	IDR 916.91bn
Cash and short-term investments	IDR 368.74bn	IDR 543.81bn	IDR 442.46bn	IDR 171.79bn	IDR 237.93bn	IDR 106.53bn	IDR 87.68bn	IDR 76.67bn
Debt	IDR 2.31bn	IDR 2.54bn	IDR 14.23bn	IDR 15.15bn	IDR 17.31bn	IDR 18.07bn	IDR 7.56bn	IDR 18.45bn
Shareholders' equity	IDR 964.29bn	IDR 1.04trn	IDR 975.71bn	IDR 833.21bn	IDR 829.78bn	IDR 820.47bn	IDR 807.27bn	IDR 729.58bn

Financial ratios

Data as of 29 Aug 2026

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Gross margin	46.8%	38.8%	41.7%	38.0%	37.5%	44.9%	—
Operating margin	26.7%	18.6%	20.8%	21.3%	18.0%	16.5%	—
Net margin	20.3%	14.8%	18.5%	16.0%	12.4%	11.0%	—
Return on equity	25.0%	19.0%	22.4%	23.7%	19.2%	11.7%	—
Return on assets	19.2%	16.0%	18.6%	17.3%	12.8%	7.7%	—
Free cash flow yield	22.4%	4.2%	12.8%	7.5%	12.2%	5.9%	—
Revenue growth	15.8%	7.8%	-14.5%	5.7%	62.3%	-11.9%	—
Earnings growth	58.9%	-13.9%	-0.9%	36.6%	83.1%	-8.1%	—
Current ratio	4.26x	6.52x	5.74x	3.33x	2.71x	2.55x	—
Debt to equity	0.01x	0.01x	0.01x	0.01x	0.02x	0.02x	—
Equity ratio	76.7%	84.4%	83.1%	73.0%	66.7%	65.9%	—
Interest coverage	183.30x	42.54x	49.43x	70.40x	72.66x	27.32x	—
R&D as a share of sales	—	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%
Buybacks as a share of market value	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	2.2%	12.9%	2.0%
Operating income	10.3%	24.2%	5.6%
Net income	10.7%	27.7%	5.5%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	43.1%	41.5%	41.1%	43.9%
Operating margin	22.9%	22.0%	20.7%	19.2%
Net margin	17.8%	17.5%	15.9%	25.0%

Valuation history

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Price to earnings	6.2	10.5	10.5	11.8	12.6	20.4	16.3	1.7	26.3	26.8
Price to sales	1.3	1.6	1.9	1.9	1.6	2.2	1.7	3.1	3.3	4.0

Dividends and splits

Per share, in the currency the company pays

Paid for 6 years. Last went ex-dividend on 25 Jun 2025.

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2018	FY2017
Paid in the year	170.00	320.00	320.00	240.00	122.00	130.00	285.65	275.00

20-for-1 split · 21 Dec 2015

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Merck Tbk PT MERK.JK · IDR

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Financial ratios

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology